This website uses cookies to enhance the user experience.
C

CARDIACCS AS994 338 668

Research
Limited company
Gaustadalléen 21 0349 OSLO, Norge

CARDIACCS AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
15 years
since Jul 25, 2009
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
144,816
1 share class
Total number of shareholders
80
35 companies, 45 persons

Financials

Total operating income 2023
2,668,704
NOK
Annual total result 2023
-7,047,419
NOK
Total equity 2023
5,980,808
NOK
Last update: Sep 7, 2024

Management

Board

NameRoleShares
Chairman
29.46 %
directly 26.08 %
indirectly 3.37 %
Board Member
12.11 %
directly 6.03 %
indirectly 6.08 %
Board Member-
Board Member
4.89 %
directly

Others

NameRoleShares
V
VEKST REVISJON AS
Auditor-
F
FINANSTORGET AS
Accountant-
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman
29.46 %
directly 26.08 %
indirectly 3.37 %
Board Member
12.11 %
directly 6.03 %
indirectly 6.08 %
Board Member
4.89 %
directly
-
3.45 %
directly
-
3.18 %
indirectly
-
2.25 %
directly
-
2.13 %
directly
DK
-
1.97 %
directly 0.59 %
indirectly 1.38 %
-
1.73 %
directly
-
1.45 %
directly
Last update: Jun 24, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
37,773
26.08 %
Ordinary shares
8,729
6.03 %
Ordinary shares
7,085
4.89 %
U
UMO AS
Ordinary shares
6,421
4.43 %
Ordinary shares
5,000
3.45 %
H
HERE HOLDING AS
Ordinary shares
4,883
3.37 %
A
AS ANJA
Ordinary shares
4,600
3.18 %
M
MARKUSSEN EIENDOM AS
Ordinary shares
4,286
2.96 %
N
NORSK SPRINKLER AS
Ordinary shares
3,500
2.42 %
Ordinary shares
3,258
2.25 %
F
FINANSTORGET AS
Ordinary shares
3,086
2.13 %
Ordinary shares
3,081
2.13 %
S
SVEVIK AS
Ordinary shares
2,560
1.77 %
S
Ordinary shares
2,543
1.76 %
Ordinary shares
2,500
1.73 %
C
COREMED AS
Ordinary shares
2,283
1.58 %
Ordinary shares
2,100
1.45 %
G
G.G. CONSULT AS
Ordinary shares
2,037
1.41 %
R
RAMME EIENDOM AS
Ordinary shares
2,000
1.38 %
S
SKONTORP HOLDING AS
Ordinary shares
2,000
1.38 %
Ordinary shares
1,900
1.31 %
L
LYDER AS
Ordinary shares
1,759
1.21 %
H
HANDSUP HOLDING AS
Ordinary shares
1,653
1.14 %
S
SOL HOLDING AS
Ordinary shares
1,600
1.1 %
Ordinary shares
1,561
1.08 %
F
FIRIOL INVEST AS
Ordinary shares
1,446
1 %
I
INTERCON AS
Ordinary shares
1,423
0.98 %
Ordinary shares
1,360
0.94 %
C
CARDIACCS AS
Ordinary shares
1,283
0.89 %
Ordinary shares
1,250
0.86 %
B
BERLE HOLDING AS
Ordinary shares
1,142
0.79 %
S
SVEND AAKHUS KARDIOLOGI AS
Ordinary shares
1,102
0.76 %
P
PENTHOUSE MIRADORES AS
Ordinary shares
1,059
0.73 %
J
JAJO AS
Ordinary shares
1,000
0.69 %
L
LAAKE AS
Ordinary shares
953
0.66 %
DK
Ordinary shares
858
0.59 %
H
HOKLAND INVEST AS
Ordinary shares
767
0.53 %
E
EWIX AS
Ordinary shares
762
0.53 %
Ordinary shares
700
0.48 %
L
LS HOLDING AS
Ordinary shares
625
0.43 %
Ordinary shares
600
0.41 %
Ordinary shares
600
0.41 %
Ordinary shares
572
0.39 %
C
CHRI AS
Ordinary shares
571
0.39 %
Ordinary shares
534
0.37 %
F
FIBULA AS
Ordinary shares
505
0.35 %
Ordinary shares
500
0.35 %
Ordinary shares
480
0.33 %
LH
Ordinary shares
450
0.31 %
Ordinary shares
436
0.3 %
Ordinary shares
436
0.3 %
T
THOV HOLDING AS
Ordinary shares
430
0.3 %
V
VALENTINE CAPITAL AS
Ordinary shares
400
0.28 %
Ordinary shares
333
0.23 %
Ordinary shares
320
0.22 %
Ordinary shares
300
0.21 %
Ordinary shares
300
0.21 %
N
NCNOR AS
Ordinary shares
300
0.21 %
Ordinary shares
285
0.2 %
Ordinary shares
200
0.14 %
D
DENOVA IMPULS AS
Ordinary shares
200
0.14 %
Ordinary shares
199
0.14 %
Ordinary shares
187
0.13 %
Ordinary shares
170
0.12 %
Ordinary shares
167
0.12 %
Ordinary shares
167
0.12 %
L
LIA CAPITAL AS
Ordinary shares
150
0.1 %
Ordinary shares
150
0.1 %
Ordinary shares
150
0.1 %
P
PINGA HOLDING AS
Ordinary shares
143
0.1 %
O
ODEXER AS
Ordinary shares
143
0.1 %
Ordinary shares
100
0.07 %
Ordinary shares
100
0.07 %
Ordinary shares
100
0.07 %
Ordinary shares
70
0.05 %
Ordinary shares
38
0.03 %
Ordinary shares
37
0.03 %
Ordinary shares
30
0.02 %
Ordinary shares
20
< 0.01 %
Ordinary shares
15
< 0.01 %

Shares owned by the CARDIACCS AS

NameShare classNumber of sharesShare
C
CARDIACCS AS
Ordinary shares
1,283
0.89 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
2,668,704
7,883,243
5,147,152
Annual Total Result
-7,047,419
-2,364,734
-2,969,975
Total assets
8,871,558
18,274,793
21,884,502
Total liabilities
2,890,750
6,475,417
10,267,341
Total equity
5,980,808
11,799,377
11,617,161

P&L

Year202320222021
Total operating income
2,668,704
7,883,243
5,147,152
Total operating costs
10,577,453
10,194,591
7,785,082
Operating result
-7,908,749
-2,311,347
-2,637,930
Financial income/costs
861,330
-53,387
-332,045
Profit before tax
-7,047,419
-2,364,734
-2,969,975
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-7,047,419
-2,364,734
-2,969,975

Balance overview

Year202320222021
Total fixed assets
1,344,462
4,193,203
4,306,204
Total current assets
7,527,096
14,081,590
17,578,298
Total assets
8,871,558
18,274,793
21,884,502
Short term debt
2,890,750
6,475,417
9,831,267
Long term debt
0
0
436,074
Total liabilities
2,890,750
6,475,417
10,267,341
Contributed capital
19,554,792
18,325,942
15,778,992
Retained earnings
-13,573,984
-6,526,565
-4,161,832
Total equity
5,980,808
11,799,377
11,617,161
Total equity and liabilities
8,871,558
18,274,794
21,884,502

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering